美國的體外受精設備市場評估:各產品類型，各次序類型，各終端用戶，各地區，機會及預測，2018～2032年

美國 IVF 設備市場預計將從 2024 年的 60.7 億美元成長到 2032 年的 85.7 億美元，預測期間（2025-2032 年）的複合年增長率為 4.41%。

由於先進技術和基礎設施的出現，以及對高效解決方案的需求不斷增加，美國 IVF 市場取得了顯著增長。推動該國市場擴張的主要因素之一是由於久坐的生活方式和環境條件的變化導致很大一部分人口的生殖功能下降。如今，圍繞生殖醫學的禁忌正在解除，隨著公眾意識的提高，人們越來越願意接受生殖醫學。此外，政府還透過監管和保險支援、醫療保健基礎設施投資、技術進步以及對尖端解決方案的需求不斷增長等形式推動市場的成長軌跡。

例如，Fertility USA 和 Ovation Fertility 於 2023 年 4 月宣佈建立合作夥伴關係，成為美國最知名的不孕症治療組織。該聯盟透過應用行業最佳實踐來提高可及性、患者滿意度和健康結果，尋求促進創新和發展。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 美國的體外受精設備市場預測，2018年～2032年

• 市場規模的分析與預測
  • 各金額
• 市場佔有率分析與預測
  • 各產品類型
    • 設備
    • 試劑和培養基
    • 軟體和服務
  • 各次序類型
    • 新鮮捐贈者的體外受精
    • 新鮮的非捐贈者體外受精
    • 凍結捐贈者體外受精
    • 凍結非捐贈者體外受精
    • 自然地週期體外受精
    • 其他
  • 各終端用戶
    • 不孕治療診所
    • 醫院
    • 調查機關及學術中心
    • 冷凍銀行
  • 各地區
    • 東北部
    • 中西部
    • 西部
    • 南部
  • 市場佔有率分析(前五名公司以及其他- 各金額，2024年)，各企業
• 市場地圖分析，2024年
  • 各產品類型
  • 各次序類型
  • 各終端用戶
  • 各地區

第5章 需求供給分析

第6章 價值鏈分析

第7章 波特的五力分析

第8章 大環境分析

第9章 價格分析

第10章 市場動態

• 推動市場要素
• 市場課題

第11章 市場趨勢與發展

第12章 法規結構和革新

• 專利形勢
• 法規當局的認證
• 革新/新興技術

第13章 案例研究

第14章 競爭情形

• 前五名市場領導公司的競爭矩陣
• 前五名公司的SWOT分析
• 前十大市場主要企業的形勢
  • Becton, Dickinson and Company
  • 公司概要
  • 主要經營團隊
  • 產品和服務
  • 財務狀況(如報告)
  • 主要市場焦點和地理存在感
  • 最近的趨勢/合作/夥伴關係/合併和收購
  • CooperSurgical, Inc.
  • Thermo Fisher Scientific Inc.
  • Irvine Scientific Inc.
  • MilliporeSigma(Merck KGaA)
  • Vitrolife Inc.
  • Eppendorf North America, Inc.
  • Leica Biosystems, Inc.
  • Hamilton Company
  • Origio USA, Inc.

上述公司不依市場佔有率排序，並且可能會根據研究工作期間獲得的資訊進行更改。

第15章 策略性建議

第16章 關於調查公司·免責聲明

United States in-vitro fertilization instruments market is projected to witness a CAGR of 4.41% during the forecast period 2025-2032, growing from USD 6.07 billion in 2024 to USD 8.57 billion in 2032.

The United States market for in-vitro fertilization has grown significantly because of the availability of advanced techniques and infrastructure coupled with the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health as a result of sedentary lifestyles and shifting environmental conditions. The taboo which is still associated with it is now dissolving and people are more freely availing these medical options as awareness spreads more around the country. Furthermore, the market's growth trajectory is being reinforced by the government in the form of regulatory and insurance support and the investments they make in healthcare infrastructure, advancements in technology, and the growing demand for cutting-edge solutions.

For example, U.S. Fertility & Ovation Fertility announced a partnership arrangement in April 2023 to become the most well-known fertility organization in the United States. By applying industry best practices to improve accessibility, patient satisfaction, and health outcomes, the alliance seeks to spur innovation and growth.

Technological Advancements in In-Vitro Fertilization Instruments Boosts Market Growth

Reproductive technology advancements have transformed IVF procedures in the US, increasing success rates and simplifying treatment plans. Clinics are now able to maximize embryo viability and minimize treatment cycles due to recent innovations such as AI-driven embryo selection tools, enhanced time-lapse imaging, and sophisticated cryopreservation methods such as vitrification. By increasing the likelihood of a successful pregnancy, these improvements boost professional efficiency and patient confidence.

For instance, in May 2023, Genea Biomedx Pty Ltd (a subsidiary of Genea Group) and AIVF Ltd. came together in a partnership to launch an integrated solution for personalized IVF care at a low cost. The integrated suite was built based on the Geri time-lapse incubator of Genea Biomedx and the EMA AI platform of AIVF.

According to reports, this technology improves embryo selection results by more than 25% when compared to traditional approaches by using deep-learning algorithms to evaluate embryo quality with previously unheard-of accuracy. Such advancements in technology not only demonstrate the revolutionary effects of digital health solutions in IVF but also highlight the market's dedication to further advancements in reproductive care. The US IVF market is expanding significantly because of the integration of these advancements, which improves treatment accessibility and efficacy.

Rising Infertility Rates and Changing Demographics Expedite the country's In-Vitro Fertilization Instruments Market Growth

Infertility rates in the United States are on the rise, primarily because of environmental causes, lifestyle-related health problems, and postponed childbirth. The need for assisted reproductive technologies, especially IVF, has increased as more people decide to have children later in life. Epidemiological statistics from 2023 suggested a considerable increase in infertility among women over 35, prompting both public awareness and aggressive fertility planning.

For example, Reproductive Health Partners, a well-known fertility centre in California, reported a 15% increase in IVF treatment cycles year over year in June 2023. This pattern is consistent with a larger demographic shift in which socioeconomic considerations and career-oriented lives cause people to put off family planning, which increases the need for medical intervention to conceive. As patients and healthcare professionals increasingly see IVF as a practical and occasionally required solution to age-related and lifestyle-induced fertility issues, the combination of rising infertility rates and changing societal standards has produced a favorable environment for market expansion.

Enhanced Regulatory and Insurance Support Fuel the US In-Vitro Fertilization Instruments Market Growth

Government policies and private insurance reforms in the United States have played a pivotal role in broadening access to IVF treatments. Increased regulatory support, along with mandates for better insurance coverage of fertility services, has lowered financial barriers, encouraging more couples to consider IVF.

In 2023, New York State enacted updated healthcare regulations that expanded insurance coverage for fertility treatments, including IVF, ensuring more patients could afford these procedures. Building on this momentum, in February 2024, a major private insurer, Blue Cross Blue Shield Association, announced a nationwide expansion of its fertility benefits program. This initiative significantly reduced out-of-pocket expenses for patients and spurred additional investments by clinics in advanced IVF technologies. Such regulatory and insurance advancements not only alleviate the financial burden on prospective parents but also stimulate market growth by increasing treatment accessibility. This supportive ecosystem is critical in driving demand and ensuring sustained growth in the competitive US IVF landscape.

Future Market Scenario (2025-2032F)

Many factors claim the growth of the United States in-vitro fertilization instruments market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing number of fertility concerns that the population is facing today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.

For instance, in January 2024, IVIRMA Global SL, a global medical institution acquired Eugin Group's North American Operations, which included the Boston IVF fertility network and Toronto-based TRIO. The plan is to ensure the success of many patients while offering evidence-based fertility options.

Key Players Landscape and Outlook

Key players in the United States in-vitro fertilization industry leverage strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, Ovation Fertility and US Fertility merged in May 2023 to build a fertility platform that provides IVF and advanced fertility care in the United States.

Boston IVF and Cryoport, Inc. signed a three-year supply chain solutions agreement in April 2023 to facilitate the shipping of reproductive materials around the United States.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States In-vitro Fertilization Instruments Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Equipment
      • 4.2.1.1.1. Incubators
      • 4.2.1.1.2. Cryosystems
      • 4.2.1.1.3. Imaging Systems
      • 4.2.1.1.4. Ovum Aspiration Pumps
      • 4.2.1.1.5. Micromanipulators
      • 4.2.1.1.6. Sperm Separation Systems
      • 4.2.1.1.7. Others
    • 4.2.1.2. Reagents and Media
      • 4.2.1.2.1. Embryo Culture Media
      • 4.2.1.2.2. Cryopreservation Media
      • 4.2.1.2.3. Sperm Processing Media
      • 4.2.1.2.4. Others
    • 4.2.1.3. Software and Services
  • 4.2.2. By Procedure Type
    • 4.2.2.1. Fresh Donor IVF
    • 4.2.2.2. Fresh Non-Donor IVF
    • 4.2.2.3. Frozen Donor IVF
    • 4.2.2.4. Frozen Non-Donor IVF
    • 4.2.2.5. Natural Cycle IVF
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Fertility Clinics
    • 4.2.3.2. Hospitals
    • 4.2.3.3. Research Institutes and Academic Centers
    • 4.2.3.4. Cryobanks
  • 4.2.4. By Region
    • 4.2.4.1. Northeast
    • 4.2.4.2. Midwest
    • 4.2.4.3. West
    • 4.2.4.4. South
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Product Type
  • 4.3.2. By Procedure Type
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Patent Landscape
• 12.2. Regulatory Approvals
• 12.3. Innovations/Emerging Technologies

13. Case Studies

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Becton, Dickinson and Company
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. CooperSurgical, Inc.
  • 14.3.3. Thermo Fisher Scientific Inc.
  • 14.3.4. Irvine Scientific Inc.
  • 14.3.5. MilliporeSigma (Merck KGaA)
  • 14.3.6. Vitrolife Inc.
  • 14.3.7. Eppendorf North America, Inc.
  • 14.3.8. Leica Biosystems, Inc.
  • 14.3.9. Hamilton Company
  • 14.3.10. Origio USA, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States In-vitro Fertilization Market, By Value, In USD Billion, 2018-2032F
• Figure 2. United States In-vitro Fertilization Market Share (%), By Product Type, 2018-2032F
• Figure 3. United States In-vitro Fertilization Market Share (%), By Procedure Type, 2018-2032F
• Figure 4. United States In-vitro Fertilization Market Share (%), By End-user, 2018-2032F
• Figure 5. United States In-vitro Fertilization Market Share (%), By Region, 2018-2032F
• Figure 6. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 7. By Procedure Type Size Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 8. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024